While it is premature to speculate on the clinical use of environmental enrichment as compared to CRHR1 antagonists for endometriosis, the fact that both studies showed a similar decrease in the vesicle development opens the possibility for exploring new treatment options targeting the CRH signaling either with pharmacology or with environmental approached aimed at reducing stress. This evidence concerns the gene CRHR1 and endometriosis.